• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Viasys Healthcare

Viasys Healthcare

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. AmpliPhi Biosciences Provides Update on Phase 1 Trial in Chronic Rhinosinusitis Patients

    AmpliPhi Biosciences Provides Update on Phase 1 Trial in Chronic Rhinosinusitis Patients

  2. How insurers are losing when it comes to variable annuities

    Tight restrictions are placed on investment options in VAs with guaranteed income to reduce their risk. Returns have lagged as a result, frustrating advisers and investors.

  3. MetLife VAs flounder as Fidelity halts sales

    The insurer's variable annuities dipped 39% year-over-year in the second quarter, offering a glimpse into the power of big distributors like Fidelity.

  4. What Advisors Don’t Know About Variable Annuities: Market Conditions and VAs

    In part four of our series, we look at how market conditions affect variable annuities. VAs may appear, on paper, to be a win-win, but the reality is more nuanced.

  5. Top 5 Vendors in the Cloud-Based Value-Added Services Market From 2016 to 2020: Technavio

    Top 5 Vendors in the Cloud-Based Value-Added Services Market From 2016 to 2020: Technavio

  6. Global Cloud-based Value-added Services Market 2016-2020 - Key Vendors are Cisco Systems, Huawei, IBM, Infosys & Ericsson - Research and Markets

    Global Cloud-based Value-added Services Market 2016-2020 - Key Vendors are Cisco Systems, Huawei, IBM, Infosys & Ericsson - Research and Markets

  7. Fixed indexed annuity sales gaining on VAs : Cerulli

    Fixed indexed annuity sales are steadily gaining on those of variable annuities, thanks in large part to continued low interest rates.

  8. Finra targets variable annuities as 'sweet spot' of scrutiny

    Following record MetLife fine, regulator says VAs are now at the core of their focus: complex products marketed to seniors.

  9. Jackson National to offer DoubleLine smart beta fund in VAs

    Smart-beta strategies got their latest seal of approval in the form of a $100 million mandate from variable annuity giant Jackson National, which has added the DoubleLine Shiller Enhanced CAPE Fund to its menu of VA investment options.

  10. Time for More ETF-Based VAs

    ETFs could help solve the high costs that dog variable annuities.

123
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.